UNH Lead Plaintiff Deadline Approaching – Stockholders Should Contact Robbins LLP for Information

Core Viewpoint - A class action lawsuit has been filed against UnitedHealth Group, Inc. for allegedly failing to disclose a Department of Justice (DOJ) investigation related to its acquisition of Change Healthcare, which has resulted in significant shareholder losses [1][2]. Allegations - The lawsuit claims that UnitedHealth announced an agreement to acquire Change Healthcare on January 6, 2021, but the DOJ filed a lawsuit on February 24, 2022, challenging the acquisition on antitrust grounds [1][2]. - The DOJ's concerns were based on the belief that the merger would provide UnitedHealth with excessive access to sensitive health data, potentially violating antitrust laws [1]. - On February 27, 2024, it was reported that the DOJ had reopened its investigation into UnitedHealth, leading to a stock price decline of $27 per share, equating to a loss of nearly $25 billion in shareholder value [2]. Insider Trading - The complaint alleges that UnitedHealth was aware of the DOJ investigation since at least October 2023 and that insiders sold over $120 million worth of their shares without disclosing this information to investors [2]. Class Action Participation - Shareholders interested in participating in the class action must file motions by July 15, 2024, to serve as lead plaintiffs, representing the interests of other class members [3].